Performance of the Affymetrix GeneChip HIV PRT 440 platform for antiretroviral drug resistance genotyping of human immunodeficiency virus type 1 clades and viral isolates with length polymorphisms.
The performance of a silica chip-based resequencing method, the Affymetrix HIV PRT 440 assay (hereafter referred to as the Affymetrix assay), was evaluated on a panel of well-characterized nonclade B viral isolates and on isolates exhibiting length polymorphisms. Sequencing of human immunodeficiency virus type 1 (HIV-1) pol cDNAs from clades A, C, D, E, and F resulted in clade-specific regions of base-calling ambiguities in regions not known to be associated with resistance polymorphisms, as well as a small number of spurious resistance polymorphisms. The Affymetrix assay failed to detect the presence of additional serine codons distal to reverse transcriptase (RT) codon 68 that are associated with multinucleoside RT inhibitor resistance. The increasing prevalence of non-clade B HIV-1 strains in the United States and Europe and the identification of clinically relevant pol gene length polymorphisms will impact the generalizability of the Affymetrix assay, emphasizing the need to accommodate this expanding pool of pol genotypes in future assay versions.
Vahey
M
M
Division of Retrovirology, Walter Reed Army Institute of Research, Rockville, Maryland 20850, USA. mvahey@pasteur.hjf.org
Nau
M E
ME
Barrick
S
S
Cooley
J D
JD
Sawyer
R
R
Sleeker
A A
AA
Vickerman
P
P
Bloor
S
S
Larder
B
B
Michael
N L
NL
Wegner
S A
SA
D000163:Acquired Immunodeficiency Syndrome / Q000821:virology*; D001681:Biological Assay / Q000379:methods*; D004352:Drug Resistance, Microbial / Q000235:genetics*; D016679:Genome, Viral; D015497:HIV-1 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D008828:Microbiological Techniques; D012150:Polymorphism, Restriction Fragment Length; D012367:RNA, Viral / Q000032:analysis / Q000235:genetics
D012367:RNA, Viral